Navigation Links
Vasogen to Conduct Year-end 2007 Conference Call
Date:1/11/2008

MISSISSAUGA, ON, Jan. 11 /PRNewswire-FirstCall/ - Vasogen Inc. (NASDAQ:VSGN; TSX:VAS), a biotechnology Company focused on the research and commercial development of technologies targeting the chronic inflammation underlying cardiovascular and neurological disease, will release its year-end results at 4:10 p.m. on Wednesday, January 16, 2008. A conference call will follow at 4:30 p.m. Eastern Time, during which management will provide a Company update and discuss year-end results.

To participate via webcast, please go to http://www.vasogen.com. To participate by telephone, please connect 10 minutes prior to the call to one of the following:

--------------------------------

Direct Dial 416-641-6142

--------------------------------

Toll-free 1-866-542-4241

--------------------------------

A re-broadcast of the conference call will be available at http://www.vasogen.com and may also be accessed by:

--------------------------------

Direct Dial 416-695-5800

--------------------------------

Toll-free 1-800-408-3053

--------------------------------

Passcode 3248350

--------------------------------

About Vasogen:

Vasogen is a biotechnology company engaged in the research and commercial development of therapies designed to target the destructive inflammatory proces
'/>"/>

SOURCE Vasogen Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Vasogen and Grupo Ferrer Announce Initial Roll-out of Celacade - New Therapy for Chronic Heart Failure
2. Vasogen Provides an Update on ACCLAIM-II Preparations
3. Vasogen to Webcast Presentations at Three Upcoming Healthcare Conferences
4. Vasogen Announces Third Quarter 2007 Results
5. Vasogen Announces Third Quarter Conference Call and Webcast of Bio InvestorForum 2007 Presentation
6. Hybrid semiconductors show zero thermal expansion; Could lead to hardier electronics
7. Katie Lee Joel to Conduct Free, Hands-On, Holiday Cooking Demonstration for Local Patients With Chronic Kidney Disease
8. NanoMaterials Technology to Conduct Process Development Feasibility Study with US Based Emerging Pharmaceutical Company
9. CryoLife to Conduct Annual Cardiac Surgery Fellows Allograft Symposium
10. Doping technique brings nanomechanical devices into the semiconductor world
11. IBM and Imago find a crucial difficulty in semiconductor device scaling

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... The world,s first concept demonst... breakthrough alternative to replace a petrochemic...thetic rubber with renewable biomass, made their d...ill be on display at a lounge in the common depart...hroughout December 21, while the other tire will m...
(Date:12/2/2009)...ss., Dec. 2 TechConnect World, an ...development and product integration in cleantech, ... 11th deadline for technology abstracts and busine...Connect World, in association with the Nano Scienc...echnology and Sustainable Industries Organization ...
(Date:12/2/2009)... /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (N... biopharmaceutical company focused on endocrine th...Food and Drug Administration (FDA) has granted Fas...hway inhibitor compound, perifosine (KRX-0401), fo...eloma. Keryx Biopharmaceuticals, Inc. ("Keryx") ( ...
(Date:12/1/2009)...., Dec. 1 PDL BioPharma,...ue guidance for the fourth quarter ended December ... with $69 million for the fourth quarter of 2008. ...rst of two installment payments of $12.5 million f... results was a one-time $1.8 million payment from ...
Breaking Biology Technology:The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3
...24 /PRNewswire-Asia-FirstCall/ -- China Sky One,Me...ny") (Nasdaq: CSKI ), a,leading fully integrated...,drugs in the People,s Republic of China ("PRC"), ...Peng Lai Jin Chuang Pharmaceutical Company ("Jin,C...t with Shaanxi Buchang,Group ("Buchang") for Nafto...
...wswire-FirstCall/ - Angiotech Pharmaceuticals, Inc...pharmaceutical and medical device company, today a...ear end conference call. The call will take place ...2009. , , , Dial information for the earnings ...s follows:, North America (toll-free): (800) 29...
... 24 Novasys Medical, Inc., a developer,of innovat...hat Noridian,Administrative Services, LLC, a regio...e states, is now covering the non-surgical Renessa...nce (SUI). Noridian currently,administers benefit...es in,Alaska, Arizona, Montana, North and South Da...
Other Biology Technology:China Sky One Medical, Inc. Signs Exclusive Distribution Agreement with Shaanxi Buchang Group for Naftopidil Dispersible Tablets 2China Sky One Medical, Inc. Signs Exclusive Distribution Agreement with Shaanxi Buchang Group for Naftopidil Dispersible Tablets 3Noridian Medicare Now Covers Renessa(R) Treatment for Incontinence in Women 2
(Date:12/3/2009)...80s, Harald zur Hausen and his co-workers discover...V) cause cervical cancer. Scientists soon found ou...t is known today that the main culprits are viral ...rent cellular control functions, thus promoting ce...-workers at DKFZ have now discovered another mecha...
(Date:12/3/2009)...HIA Now in its 32nd year, the CTRC-AACR San Anton...e best in breast cancer science and world leaders ...ating breast cancer. , This year, more than 8,5...at the Henry B. Gonzales Convention Center in San ...artnership between the American Association for Ca...
(Date:12/3/2009)...ellers must be included in the design of the upcom...humanitarian crisis, according to a scientist at t...ure , Dr Simon Lewis argues that at least 50% of t...en, known as REDD (Reducing Emissions from Defores...dwellers directly, and their property rights assur...
Breaking Biology News(10 mins):Papillomavirus silences innate immune response 2CTRC-AACR San Antonio Breast Cancer Symposium continues to expand 2Forest deal at Copenhagen must avoid creating 'carbon refugees' 2New Walking Program Website Inspires Americans to Step Out and Step Up to Better Health 57058 1New Walking Program Website Inspires Americans to Step Out and Step Up to Better Health 57058 2American Imaging Management Selected to Deliver Diagnostic Imaging Management Services for ODS Health Plan 57055 1American Imaging Management Selected to Deliver Diagnostic Imaging Management Services for ODS Health Plan 57055 2Ronald O Perelman Heart Institute of NewYork Presbyterian Hospital Weill Cornell Medical Center Opens as a Center for Innovative World Class Cardiac 57052 1Ronald O Perelman Heart Institute of NewYork Presbyterian Hospital Weill Cornell Medical Center Opens as a Center for Innovative World Class Cardiac 57052 2Ronald O Perelman Heart Institute of NewYork Presbyterian Hospital Weill Cornell Medical Center Opens as a Center for Innovative World Class Cardiac 57052 3Ronald O Perelman Heart Institute of NewYork Presbyterian Hospital Weill Cornell Medical Center Opens as a Center for Innovative World Class Cardiac 57052 4Ronald O Perelman Heart Institute of NewYork Presbyterian Hospital Weill Cornell Medical Center Opens as a Center for Innovative World Class Cardiac 57052 5
... St. Jude Children,s Research Hospital have discov... ready to change its identity that it requires the...suade it. , The researchers showed that Prox1 ac...ent to reprogram a specialized type of cell, calle...ce of active Prox1, the LEC actually loses its ide...
...ow demonstrate how a tight junction protein called...g fit. The study will be published in the December...www.jcb.org ). , Like the rubber coating on a cop... glial cells that spirals around the axons of neur...nt leakage from axons and aids electrical conducti...
... Latina women have a lower risk of breast cancer t...but those with higher European ancestry could be a...he December 1 issue of Cancer Research , a journa... , "We need to study the possible factors that ar...t greater risk," said Laura Fejerman, Ph.D., a pos...
Other Biology News:Reprogrammable cell type depends on a single gene to keep its identity 2European ancestry increases breast cancer risk among Latinas 2
Combination Roto Shake Genie from Femto Scientific
GIBCO MarrowMAX Bone Marrow Medium from Invitrogen
Rat Adrenal from Pel-Freez Biologicals
GIBCO CMRL Medium-1066 (1X) liquid from Invitrogen
Biology Products: